Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
‘An IPO May Not Have Delivered Fair Value’ – Biocon Biologics CEO Tambe Sets Out Merger Rationale
Integration With Biocon Ltd Is ‘The Next Chapter In Our Evolution’
Jan 21 2026
•
By
Dave Wallace
Shreehas Tambe talks to Generics Bulletin for an exclusive Q&A
(Biocon)
More from Strategy
More from Business